aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis
aTyr Pharma Presents Additional Findings from Phase 3 EFZO-FIT Study in Late-Breaking Oral Abstract at the European Respiratory Society Congress 2025
aTyr Pharma Announces Topline Results from Phase 3 EFZO-FIT Study of Efzofitimod in Pulmonary Sarcoidosis
Cartier Extends Mineralized System 4 km East of Main; Cuts 23.2 g/t Au over 1.0 m at Nordeau ; Expands High-Grade Gold Near Surface at East Nordeau Zone
NevGold Drills 8.51 g/t Oxide AuEq Over 10.6 Meters Within 2.32 g/t Oxide AuEq Over 86.8 Meters ; Discovers High-Grade Oxide Gold-Antimony "Armory Fault" Structure At Bullet Zone
